𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinguishing clinical and electrodiagnostic features of X-linked bulbospinal neuronopathy

✍ Scribed by Matthew N. Meriggioli; Julie Rowin; Donald B. Sanders


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
86 KB
Volume
22
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis


X-linked bulbospinal neuronopathy (XLBSN) or Kennedys disease is a rare inherited neuromuscular disease characterized by adultonset muscle weakness, usually in a limb-girdle distribution. It is frequently misdiagnosed despite a distinctive clinical presentation, usually due to the absence of a clear family history, and perhaps also due to failure of recognition. Accurate diagnosis is crucial for genetic counseling purposes and because alternative diagnoses usually carry a poorer prognosis. We evaluated 4 patients with XLBSN and one symptomatic female heterozygote patient. Based on our clinical observations in these patients and a systematic review of previously reported cases, the following clinical and electrophysiologic features when present in the setting of adult-onset muscle weakness, are strongly suggestive of the disorder: 1) facial weakness, 2) facial twitching or fasciculations, 3) tongue weakness and atrophy, 4) postural hand tremor, 5) hypo-or areflexia, and 6) absent or low-amplitude sensory nerve action potentials despite clinically normal sensation. We also hypothesize regarding the possibility of partial expression of the abnormal XLBSN gene in a symptomatic heterozygote female patient.


πŸ“œ SIMILAR VOLUMES


Incidence and clinical features of X-lin
✍ Guntram Borck; Mohamed Zarhrate; Jean-Paul Bonnefont; Arnold Munnich; ValΓ©rie Co πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

Cornelia de Lange syndrome (CdLS) is a multisystem developmental disorder characterized by facial dysmorphism, growth and mental retardation, microcephaly, and various malformations. Heterozygous mutations in the NIPBL gene have been detected in approximately 45% of affected individuals. Recently, a